Efficacy of TVT-SECUR and factors affecting cure of female stress urinary incontinence: 3-year follow-up.

International Urogynecology Journal
Ji-Yeon HanMyung-Soo Choo

Abstract

The aim of this study was to evaluate the efficacy of the TVT-SECUR procedure for treating stress urinary incontinence (SUI) and to identify factors affecting cure during 3 years of follow-up. We prospectively followed patients until 1 year postoperatively and contacted them to revisit the clinic at 3 years. Ninety-six women who underwent TVT-SECUR (H type: 42, U type: 54) were followed up for at least 3 years. Patients were evaluated using the Severity Index for Urinary Incontinence, the Incontinence Quality of Life questionnaire, and the Bristol Female Lower Urinary Tract Symptom-Short Form questionnaire at baseline and at each postoperative visit. Patient satisfaction and complications were evaluated. Surgical outcome was assessed according to the Severity Index for Urinary Incontinence. Multivariate regression analysis was used to identify preoperative factors independently associated with cure. The 3-year success rate was 91.7 % (cure 72.9 %, improved 18.8 %). The success rate was maintained from 94.8 % at 1 year to 91.7 % at 3 years, but the cure rate decreased significantly from 85.4 % at 1 year to 72.9 % at 3 years. Patient satisfaction rate was 85.4 %. Cure rates were lower in patients with Valsalva leak point pressure...Continue Reading

References

Jan 1, 1996·International Urogynecology Journal and Pelvic Floor Dysfunction·U UlmstenG Varhos
Jul 14, 2001·International Urogynecology Journal and Pelvic Floor Dysfunction·M Rezapour, U Ulmsten
Dec 7, 2006·Neurourology and Urodynamics·Donna Y DengLarissa V Rodriguez
Jun 10, 2008·Journal of Minimally Invasive Gynecology·Menahem Neuman
Nov 28, 2008·International Urogynecology Journal and Pelvic Floor Dysfunction·Michele MeschiaLorenzo Spreafico
Feb 14, 2009·International Urogynecology Journal and Pelvic Floor Dysfunction·Petr HubkaJana Zvarova
Feb 17, 2009·International Urogynecology Journal and Pelvic Floor Dysfunction·Alois MartanMarketa Pavlikova
May 1, 2009·Journal de gynécologie, obstétrique et biologie de la reproduction·P DebodinanceB Jacquetin
Jul 15, 2009·International Urogynecology Journal and Pelvic Floor Dysfunction·R Marijn HouwertHarry A M Vervest
Mar 6, 2010·International Urogynecology Journal·Dirk De RidderFrank Van der Aa
May 4, 2010·European Urology·Jean-Nicolas CornuFrancois Haab
May 5, 2010·International Urogynecology Journal·Kirsi PalvaCarl Gustaf Nilsson
May 19, 2010·The New England Journal of Medicine·Holly E RichterUNKNOWN Urinary Incontinence Treatment Network
Jun 17, 2010·International Urogynecology Journal·Xavier DeffieuxHervé Fernandez
Aug 28, 2010·International Urogynecology Journal·Petr HubkaJaromir Masata

❮ Previous
Next ❯

Citations

Sep 17, 2013·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Manuel F Montesino-SemperDiego García-García
Mar 20, 2014·International Urogynecology Journal·Ana Maria H M Bianchi-FerraroManoel J B C Girão
Oct 24, 2014·International Urogynecology Journal·Burhan CoskunPhilippe E Zimmern
Jan 16, 2015·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Giovanni A TommaselliCarmine Nappi
Apr 14, 2017·Journal of Obstetrics and Gynaecology of India·Arun Nayak

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.